Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Aldeyra Plans To File Reproxalap Again With New Dry Eye Symptom Data
May 06 2025
•
By
Joseph Haas
Aldeyra plans to take its dry eye candidate to the FDA for a third shot at approval • Source: Alamy
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Strategy
More from Therapy Areas